HIV-related tuberculosis in British Columbia: Indications of a rise in prevalence and a change in risk groups

Clinical and Investigative Medicine

Volumn 19, Issue 4, 1996, Pages 271-278

  Blenkush, Mary F ^a   Korzeniewska Kozela, M ^b   Kevin Elwood, R ^a   Black, William ^c   Mark Fitzgerald, J ^a,c,d  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b INSTYTUT GRU LICY I CHORÓB P UC   (Poland)

^c BRITISH COLUMBIA CENTRE FOR DISEASE CONTROL   (Canada)

^d VANCOUVER HOSPITAL AND HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ABORIGINE; ADULT; AGED; ARTICLE; BACTERIUM CULTURE; CANADA; CAUSE OF DEATH; CLINICAL ARTICLE; DEMOGRAPHY; DRUG TOXICITY; FEMALE; HIGH RISK POPULATION; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; MALE; MORTALITY; PRIORITY JOURNAL; RASH; RISK FACTOR; SCREENING; TREATMENT OUTCOME; TUBERCULOSIS;

ADULT; AGED; AIDS-RELATED OPPORTUNISTIC INFECTIONS; BRITISH COLUMBIA; EPIDEMIOLOGY; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; RISK-TAKING; SEX FACTORS; TUBERCULOSIS, PULMONARY;

EID: 0029764622     PISSN: 0147958X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Harries AD. Tuberculosis and human immunodeficiency virus infection in developing countries. Lancet 1990;335:387-90.
2. Schulzer M, FitzGerald JM, Enarson DA, et al. An estimate of the future size of the tuberculosis problem in sub-Saharan Africa resulting from HIV infection. Tuber Lung Dis 1992;73:52-8.
3. Selwyn PA, Hartel D, Lewis VA, et al. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med 1989;320:545-50.
4. Division of HIV/AIDS Epidemiology, Health Canada. Quarterly Surveillance Update: AIDS in Canada, Ottawa: Health Canada, Oct 1994.
5. Division of Tuberculosis Control, British Columbia Ministry of Health. Annual Report. Vancouver: Ministry of Health, 1992.
6. Korzeniewska-Kozela M, FitzGerald JM, Vedal S, et al. Spectrum of tuberculosis in patients with HIV infection in British Columbia: report of 40 cases. Can Med Assoc J 1992;146:1927-34.
7. Canadian Tuberculosis and Respiratory Disease Association. Classification and Reporting of Tuberculosis in Canada. Ottawa: The Association, 1969.
8. Canadian Centre for Health Information, Statistics Canada. The Canadian Tuberculosis Reporting System. Ottawa: Statistics Canada, 1990.
9. Tuberculosis and human immunodeficiency virus infection: recommendations of the Advisory Committee for the Elimination of Tuberculosis (ACET). MMWR 1989;38:236-50.
10. Onorato I, McCombs S, Morgan WM, et al. HIV infection in patients attending tuberculosis clinics, United States, 1988-92 [abstract 1363). 33rd International Conference on Antimicrobial Agents; 1993 Oct 20; New Orleans.
11. Watson JM, Meridith SK, Whitmore-Overton E, et al. Tuberculosis and HIV: estimates of the overlap in England and Wales. Thorax 1993;48(3):199-203.
12. Remis RS, Tannenbaum T. Tuberculosis and AIDS in Quebec. Can AIDS News 1994;4:11.
13. Reichman LB, Felton CP, Edsall JR. Drug dependence, a possible new risk factor for tuberculosis disease. Arch Intern Med 1979;139:337-9.
14. Des Jarlais D, Hunt DE. AIDS and intravenous drug use. AIDS Bull 1988;Feb:1-6.
15. Brudney E, Dobkin J. Resurgent tuberculosis in New York City: human immunodeficiency virus, homelessness, and the decline of tuberculosis control programs. Am Rev Respir Dis 1991;144:745-9.
16. Jones BE, Otaya M, Antoniskis D, et al. A prospective evaluation of antituberculosis therapy in patients with human immunodeficiency virus infection. Am J Respir Crit Care Med 1994;150:1499-1502.
17. Nolan CM, Elarth AM, Barr H, et al. An outbreak of tuberculosis in a shelter for homeless men: a description of its evolution and control. Am Rev Respir Dis 1991;143:257-61.
18. Weis SE, Slocum PC, Blais FX, et al. The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis. N Engl J Med 1994;330:1179-84.
19. Initial therapy for tuberculosis in the era of multidrug resistance: recommendations of the Advisory Council for the Elimination of Tuberculosis. MMWR 1993;42(RR-7):1-7.
20. Guidelines for the identification, investigation and treatment of individuals with concomitant tuberculosis and HIV infection. Can Commun Dis Rep 1992;18:155-60.
21. Perriens JH, St. Louis ME, Mukadi YB, et al. Pulmonary tuberculosis in HIV infected patients in Zaire. A controlled trial of treatment for either 6 or 12 months. N Engl J Med 1995;332:779-84.
22. Hamadeh MA, Glassroth J. Tuberculosis and pregnancy. Cheat 1992;101:1114-20.
23. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 1994;331:1173-9.
24. Pape JW, Jean SS, Ho JL, et al. Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection. Lancet 1993;342:268-72.
25. Phillips P, Montaner JG, Craib KJ, et al. Prevention of respiratory disease among HIV infected individuals: compliance with current guidelines within a cohort of homosexual men [abstract]. Can J Infect Dis 1993;4(suppl B):30-B
26. Whalen C, Horsburgh CR, Hom D, et al. Accelerated course of human immunodeficiency virus infection after tuberculosis. Am J Respir Crit Care Med 1995;151:129-35.
27. Di Perri G, Danzi MC, DeChecchi G, et al. Nosocomial epidemic of active tuberculosis among HIV-infected patients. Lancet 1989;2:1502-4.
28. Daley CL, Small PM, Scheeler GF, et al. An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. N Engl J Med 1992;326:231-5.
29. Johnson MP, Chaisson RE. Tuberculosis and HIV disease. In: Volberding PA, Jacobson MA, editors. AIDS Clinical Review 1993-94. New York: Marcel Dekker, 1994:75-93.
30. Small PM, Hopewell PC, Singh SP, et al. The epidemiology of tuberculosis in San Francisco: a population-based study using conventional and molecular methods. N Engl J Med 1994;330:1703-9.
31. Genewein A, Telenti A, Bernasconi C, et al. Molecular approach to identifying route of transmission of tuberculosis in the community. Lancet 1993;342:841-4.
32. FitzGerald JM, Kunimoto D. Use of PCR-based DNA techniques in evaluating cluster outbreaks of tuberculosis [abstract 764]. Clin Invest Med 1993;16 Suppl:B123.